Jiangzhong Pharmaceutical Co Ltd Capital Reinvestment Ratio
Jiangzhong Pharmaceutical Co Ltd capital reinvestment ratio. Jiangzhong Pharmaceutical Co Ltd (600750) has a Capital Reinvestment Ratio of 0.29x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥326.81 Million) in capital expenditures (CN¥95.46 Million). Check how aggressively does Jiangzhong Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangzhong Pharmaceutical Co Ltd (2000–2025)
Capital reinvestment ratio of Jiangzhong Pharmaceutical Co Ltd from 2000 to 2025. This chart tracks Jiangzhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods. Also explore Jiangzhong Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Jiangzhong Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2000–2025)
Jiangzhong Pharmaceutical Co Ltd capital reinvestment ratio by year from 2000 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangzhong Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥970.87 Million | CN¥280.57 Million | ▼ -21.9% |
| 2024 | 0.37x | CN¥786.25 Million | CN¥290.77 Million | ▲ +83.4% |
| 2023 | 0.20x | CN¥1.04 Billion | CN¥208.88 Million | ▼ -40.4% |
| 2022 | 0.34x | CN¥1.02 Billion | CN¥345.64 Million | ▲ +64.6% |
| 2021 | 0.21x | CN¥917.04 Million | CN¥188.49 Million | ▼ -15.3% |
| 2020 | 0.24x | CN¥752.50 Million | CN¥182.53 Million | ▲ +103.8% |
| 2019 | 0.12x | CN¥641.18 Million | CN¥76.33 Million | ▼ -52.3% |
| 2018 | 0.25x | CN¥486.25 Million | CN¥121.38 Million | ▼ -82.8% |
| 2017 | 1.45x | CN¥124.93 Million | CN¥181.21 Million | ▲ +1345.1% |
| 2016 | 0.10x | CN¥698.05 Million | CN¥70.07 Million | ▼ -18.3% |
| 2015 | 0.12x | CN¥510.78 Million | CN¥62.75 Million | ▼ -57.2% |
| 2014 | 0.29x | CN¥356.80 Million | CN¥102.33 Million | ▼ -50.3% |
| 2013 | 0.58x | CN¥111.92 Million | CN¥64.59 Million | ▼ -41.8% |
| 2012 | 0.99x | CN¥226.38 Million | CN¥224.42 Million | ▼ -32.6% |
| 2011 | 1.47x | CN¥168.30 Million | CN¥247.55 Million | ▲ +132.1% |
| 2010 | 0.63x | CN¥222.29 Million | CN¥140.86 Million | ▲ +1138.0% |
| 2009 | 0.05x | CN¥378.32 Million | CN¥19.37 Million | ▼ -32.8% |
| 2008 | 0.08x | CN¥268.87 Million | CN¥20.49 Million | ▲ +4.9% |
| 2007 | 0.07x | CN¥153.63 Million | CN¥11.16 Million | ▼ -86.9% |
| 2006 | 0.56x | CN¥55.24 Million | CN¥30.69 Million | ▲ +68.5% |
| 2005 | 0.33x | CN¥198.45 Million | CN¥65.42 Million | ▼ -96.7% |
| 2004 | 10.01x | CN¥26.28 Million | CN¥263.03 Million | ▲ +241.5% |
| 2003 | 2.93x | CN¥78.98 Million | CN¥231.42 Million | ▲ +141.0% |
| 2002 | 1.22x | CN¥94.90 Million | CN¥115.40 Million | ▲ +892.2% |
| 2001 | 0.12x | CN¥41.28 Million | CN¥5.06 Million | ▼ -45.2% |
| 2000 | 0.22x | CN¥121.77 Million | CN¥27.22 Million | — |